Valuation : ResMed Inc.

Market Cap 31.41B 27.02B 25.49B 23.22B 43.41B 3,003B 43.8B 304B 117B 1,523B 118B 115B 4,839B P/E 2027 *
18.8x
P/E 2028 * 17.2x
Enterprise Value 30.46B 26.19B 24.72B 22.52B 42.09B 2,912B 42.47B 294B 113B 1,477B 114B 112B 4,692B EV / Sales 2027 *
5.24x
EV / Sales 2028 * 4.8x
Free-Float
75.13%
Yield 2027 *
1.21%
Yield 2028 * 1.33%
1 day-7.81%
1 week-7.81%
Current month-7.81%
1 month+35.23%
3 months+33.08%
6 months-1.05%
Current year-15.41%
1 week 22.61
Extreme 22.61
22.61
1 month 22.48
Extreme 22.48
24.52
Current year 11.85
Extreme 11.85
37.91
1 year 11.85
Extreme 11.85
37.91
3 years 11.85
Extreme 11.85
37.91
5 years 1.9
Extreme 1.9
37.91
10 years 0
Extreme 0
37.91
Manager TitleAgeSince
Chief Executive Officer 53 2013-02-28
Director of Finance/CFO 40 2026-05-03
Chief Tech/Sci/R&D Officer - 2024-01-31
Director TitleAgeSince
Director/Board Member 78 2004-12-31
Chairman 53 2023-01-24
Chairman 83 1989-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-7.81%-7.81% - - 31.47B
-0.41%-2.47%+26.57%+16.38% 224B
-2.11%-4.98%+4.12%-19.26% 144B
+2.04%-2.53%-19.89%+20.87% 125B
-4.14%-8.20%-59.04%-19.99% 65.16B
-0.70%-1.00%-20.42%-13.99% 50.05B
+0.68%-3.35%+10.85%+17.15% 49.67B
-1.13%-4.57%+15.31%+25.55% 40.81B
-0.78%-2.88%+37.06%+52.38% 39.77B
-1.82%-9.20%+110.78%+27.10% 30.96B
Average -1.46%-3.67%+11.70%+11.80% 85.46B
Weighted average by Cap. -0.98%-3.34%+6.84%+8.21%

Financials

2027 *2028 *
Net sales 5.81B 5B 4.72B 4.3B 8.03B 556B 8.1B 56.16B 21.61B 282B 21.82B 21.35B 895B 6.19B 5.32B 5.02B 4.58B 8.55B 592B 8.63B 59.82B 23.02B 300B 23.25B 22.74B 953B
Net income 1.64B 1.41B 1.33B 1.21B 2.27B 157B 2.29B 15.88B 6.11B 79.67B 6.17B 6.03B 253B 1.78B 1.53B 1.45B 1.32B 2.46B 170B 2.48B 17.21B 6.62B 86.36B 6.69B 6.54B 274B
Net Debt -955M -821M -775M -706M -1.32B -91.26B -1.33B -9.22B -3.55B -46.29B -3.58B -3.51B -147B -1.69B -1.45B -1.37B -1.25B -2.34B -162B -2.36B -16.35B -6.29B -82.04B -6.35B -6.21B -261B
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
219.58USD
Average target price
246.44USD
Spread / Average Target
+12.23%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!